LOR |
SPRR3 |
||
---|---|---|---|
Gene Name | loricrin | small proline-rich protein 3 | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 7 interactors: CSTA EVPL IVL KRT1 PI3 SPRR3 VIM | 3 interactors: EVPL IVL LOR | |
Entrez ID | 4014 | 6707 | |
HPRD ID | 01070 | 01652 | |
Ensembl ID | ENSG00000203782 | ENSG00000163209 | |
Uniprot IDs | P23490 | Q9UBC9 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | analgesic
carbopol
cyclodextrin
enhancers
flux
formulated
formulation
formulations
franz
gel
gels
glycol
hp
hpmc
hydroxylpropyl
hydroxypropyl
lorf3
lorf8
lornoxicam
marketed
methylcellulose
oleic
penetration
permeation
pg
propylene
tween
viscosity
xefo
|
allowed
btc
ccnd1
differential
epigenetic
evolutionary
extensively
fgf6
functionally
hoxd3
hypermethylation
hypomethylation
insights
malignancy
methylation
mostly
nb
neuroblastic
neuroblastoma
others
outside
pathogenesis
pou2f2
prevalent
rassf1a
remarkably
stringent
supervised
untranslated
|
|
Tagcloud (Difference) ? | analgesic
carbopol
cyclodextrin
enhancers
flux
formulated
formulation
formulations
franz
gel
gels
glycol
hp
hpmc
hydroxylpropyl
hydroxypropyl
lorf3
lorf8
lornoxicam
marketed
methylcellulose
oleic
penetration
permeation
pg
propylene
tween
viscosity
xefo
|
allowed
btc
ccnd1
differential
epigenetic
evolutionary
extensively
fgf6
functionally
hoxd3
hypermethylation
hypomethylation
insights
malignancy
methylation
mostly
nb
neuroblastic
neuroblastoma
others
outside
pathogenesis
pou2f2
prevalent
rassf1a
remarkably
stringent
supervised
untranslated
|
|
Tagcloud (Intersection) ? |